CLCD

CoLucid Pharmaceuticals

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. CoLucid Pharmaceuticals, Inc. market cap is N/A.

52 week high is the highest price of a stock in the past 52 weeks, or one year. CoLucid Pharmaceuticals, Inc. 52 week high is N/A as of November 15, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. CoLucid Pharmaceuticals, Inc. 52 week low is N/A as of November 15, 2025.

CoLucid Pharmaceuticals, Inc. stock price today is $46.53.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. CoLucid Pharmaceuticals, Inc.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. CoLucid Pharmaceuticals, Inc. P/B ratio is None.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. CoLucid Pharmaceuticals, Inc.'s EBITDA is -10.29.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. CoLucid Pharmaceuticals, Inc. 50-day moving average is N/A.

CoLucid Pharmaceuticals, Inc. has N/A employees.